About
Accelerates cancer immunotherapy development with its HLA-Compass platform, a large quantitative database of HLA peptide presentation. AI-driven analytics predict off-target toxicity and support target discovery for safer, more precise therapies.
Investors and backers 1
- VivaTech Startup Challenges 2026 Accelerator · Paris
Recent news
- Tech for Change Award 2026 finalist 2026-06-05 · VivaTech